Reduced exacerbations is the goal of this drug. Continued airway clearance is crucial to this process though. So as I understand the mechanism of brinsupri, there is a reduction in production of the enzyme DPP1 produced by neutrophils which causes the inflammatory process - thus reduction in exacerbations. Staying well longer between infections is what we should notice.